NADPH Oxidase Inhibition Promotes Brain Resilience by Attenuating Tauopathy and Neuroinflammation in Alzheimer's Disease
Advanced Science · 2025
DOI: 10.1002/advs.202505495 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Jihyeon Lee und 13 weiteren Autor:innen. Beteiligte Einrichtung: Celros Biotech, 52 Ewhayeodae-Gil, Seodaemoon-Gu, Seoul, 03760, South Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, NADPH Oxidases, Tauopathies, Brain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Starting Growth Technological R&D Program, Korean National Reseach Foundation (NRF).
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) associates closely associated with the activation of NADPH oxidase (Nox) isozymes. CRB‐2131, a novel oxadiazole derivative, is identified as a potently suppresses Nox isozymes. It inhibits reactive oxygen species production (ROS) by hippocampal neuronal and microglial cells and reduces microglial activation. Prophylactic (starting at 3.5 months of age) and therapeutic (starting at 6 months of age) oral administration with CRB‐2131 for 10 weeks in 5XFAD mice reduced hippocampal superoxide levels, lipid peroxidation, Tau phosphorylation, and neuroinflammation. Prophylactic and therapeutic CRB‐2131 treatment of 5XFAD mice restored their impaired cognition as shown by the novel‐object recognition, Y‐maze, and Morris water‐maze tests. CRB‐2131 treatment increased mature neurons, reduced apoptotic mature neurons, and elevated immature neurons in the hippocampus. Positron‐emission tomography/computed‐tomography imaging confirmed that CRB‐2131 stimulated neuronal regeneration. CRB‐2131 suppresses brain oxidation, tauopathy, and neuroinflammation, thereby preventing mature neuron death and promoting neuron regeneration. Ultimately, this fosters a resilient brain and protects cognition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Celros Biotech, 52 Ewhayeodae-Gil, Seodaemoon-Gu, Seoul, 03760, South Korea.
- Department of Life Sciences, Ewha Womans University, 52 Ewhayeodae-Gil, Seodaemoon-Gu, Seoul, 03760, South Korea.
- School of Life Sciences and Biotechnology, Korea University, 145 Anam-Ro, Seongbuk-Gu, Seoul, 02841, South Korea.
- Department of Nuclear Medicine, Bundang Hospital, Seoul National University, 82 Gumi-Ro, Bundang-Gu, Seongnam City, Gyeonggi-Do, 13620, South Korea.
- Department of Nuclear Medicine, College of Medicine, Seoul National University, 103 Daehak-Ro, Jongno-Gu, Seoul, 03080, South Korea.
ORCID-Profile: Yun Soo Bae
Förderung
- Starting Growth Technological R&D Program
- Korean National Reseach Foundation (NRF)
Zitieren
APA
Lee, J., Sim, S., Jin, Y., Park, H., Byeon, E. Y., Kim, S. J., Yun, S., Lee, H. E., Jeong, D. U., Suh, J. M., Lee, I. H., Lee, H. Y., Choi, Y., & Bae, Y. S. (2025). NADPH Oxidase Inhibition Promotes Brain Resilience by Attenuating Tauopathy and Neuroinflammation in Alzheimer's Disease. Advanced Science. https://doi.org/10.1002/advs.202505495
Vancouver
Lee J, Sim S, Jin Y, Park H, Byeon EY, Kim SJ, et al. NADPH Oxidase Inhibition Promotes Brain Resilience by Attenuating Tauopathy and Neuroinflammation in Alzheimer's Disease. Advanced Science. 2025. doi:10.1002/advs.202505495
BibTeX
@article{Lee2025,
author = {Lee, Jihyeon and Sim, Seunghwan and Jin, Yinglan and Park, Hyejun and Byeon, Eun Young and Kim, Su Jin and Yun, Sujin and Lee, Hye Eun and Jeong, Da Un and Suh, Jung Min and Lee, In Hye and Lee, Ho-Young and Choi, Yongseok and Bae, Yun Soo},
title = {NADPH Oxidase Inhibition Promotes Brain Resilience by Attenuating Tauopathy and Neuroinflammation in Alzheimer's Disease},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202505495}
}
EUVIMED